Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2019.06.26

Sai’s new production block

Sai’s new production block now open for business!

The brand-new API and Intermediate manufacturing facility (Block #8) at Sai Life Sciences is the company’s largest block in terms of volume and size. It marks a 70% increase in reactor volume taking the combined capacity past 400 KL.  The project was completed in an accelerated time-frame of 15 months and had the distinction of clocking 0.5 million manhours of project execution without a single lost time incident!

In addition to the increased volumetric capacity, Block #8 provides the flexibility to handle low and high volumes in a single block with 32 reactors (16 production trains) of sizes ranging from 1 KL to 10 KL. It has next generation automation, advanced containment systems, a separate storage area for staging of raw material and intermediates, an increased ratio of filter dryers to reactors ratio, a dedicated vacuum system for every two reactors, and a 5 KL cryo reactor.

Share article

More News

2025.06.17

Peptide research center

Sai Life Sciences’ Peptide Research Center gets featured in Lab Design News

Sai Life Sciences’ newly launched Peptide Research Center was featured in Lab Design News, offering insights into the design philosophy and intent behind the facility. The article showcases how the center brings together synthesis, purification, and conjugation under one roof, with a layout optimized for high-throughput workflows and seamless cross-functional collaboration. The feature also spotlighted […]
Read more

2025.05.22

Innovator companies prefer to work with integrated partners: Krishna Kanumuri

In a recent interview with Global Business Reports, Krishna Kanumuri, CEO and Managing Director of Sai Life Sciences, highlighted a growing industry trend: innovator companies are increasingly seeking integrated partners who can support them seamlessly from discovery through development and manufacturing. As an end-to-end CRDMO in India, Sai Life Sciences is well-positioned to meet this […]
Read more

2025.05.14

Sai Life Sciences Limited reports robust FY25 results

Revenue grows by 16%; Net Profit up 105% year-on-year Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, ContractResearch, Development and Manufacturing Organization (CRDMO) announced its financial results for the fourth quarter and full year ended March 31, 2025. Financial Performance: Particulars (₹ crores) FY25 FY24 YoY% Q4FY25 Q4FY24 YoY% Revenue from […]
Read more

2025.05.12

Sai Life Sciences wins Gold at CII Southern Region Awards

Sai Life Sciences has been honored with two Gold Awards at the CII Southern Region EHS Excellence Awards 2024, recognizing the company’s exemplary Environment, Health and Safety (EHS) initiatives across its sites in India. While the Integrated R&D Centre, Hyderabad, won Gold Award for EHS Excellence & Sector 2nd Topper in Pharmaceuticals & Healthcare, the […]
Read more

2025.05.02

Sai Life Sciences certified as a Great Place To Work

Sai Life Sciences has been officially certified as a Great Place To Work for 2025–26, a recognition based on feedback from its employees.The certification reflects the company’s culture and the experiences of its people, with positive responses in key areas such as Corporate Brand Image, Competence, Pride, Team, and Leadership Behaviour. Together, these highlight the […]
Read more